A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
Clinical trial NCT02210000 · COMPLETED
Trial details
- NCT number
- NCT02210000
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-27
- Primary completion
- 2015-08-24
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.